RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
PDF herunterladen
Thromb Haemost 2006; 95(06): 1042-1043
DOI: 10.1160/TH05-12-0808
DOI: 10.1160/TH05-12-0808
Letters to the Editor
Overcoming aspirin resistance: Increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease
Authors
Weitere Informationen
Publikationsverlauf
Received
20. Dezember 2005
Accepted after resubmission
08. Mai 2006
Publikationsdatum:
30. November 2017 (online)
-
References
- 1 Cassar K, Bachoo P, Brittenden J. The role of platelets in peripheral vascular disease. EurJ Vasc Endovasc Surg 2003; 25: 6-15.
- 2 Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
- 3 Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 2002; 324: 71-86.
- 4 Wong S, Appleberg M, Ward C. et al. Aspirin resistance in cardiovascular disease: A review. Eur J Vasc Endovasc Surg 2004; 27: 456-65.
- 5 Hankey GJ, Eikelboom JW. Aspirin resistance. Lancet 2006; 367: 606-17.
- 6 Gum PA, Kottke-Marchant K, Poggio ED. et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease.[see comment]. Am J Cardiol 2001; 88: 230-5.
- 7 Favaloro EJ, Facey D, Henniker A. Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand’s disease and other disorders. AmJ Hematol 1999; 62: 165-74.
- 8 Hung J, Lam JY, Lacoste L. et al. Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin. Circulation 1995; 92: 2432-6.
- 9 Chakroun T, Gerotziafas G, Robert F. et al. In vitro aspirin resistance detected by PFA-100 closure time: pivotal role of plasma von Willebrand factor. BrJ Haematol 2004; 124: 80-5.
- 10 Yusuf S, Zhao F, Mehta SR. et al. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345: 494-502.
- 11 Perneby C, Wallen NH, Rooney C. et al. Doseand time-dependent antiplatelet effects of aspirin. Thromb Haemost 2006; 95: 652-8.